Next Article in Journal
Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report
Next Article in Special Issue
Factors Associated with COVID-19 Vaccination Promptness after Eligibility in a North Carolina Longitudinal Cohort Study
Previous Article in Journal
SARS-CoV-2 Breakthrough Infections after Third Doses Boost IgG Specific Salivary and Blood Antibodies
Previous Article in Special Issue
Efficacy and Short-Term Safety of COVID-19 Vaccines: A Cross-Sectional Study on Vaccinated People in the UAE
 
 
Article

Article Versions Notes

Vaccines 2023, 11(3), 535; https://doi.org/10.3390/vaccines11030535
Action Date Notes Link
article xml file uploaded 24 February 2023 06:48 CET Original file -
article xml uploaded. 24 February 2023 06:48 CET Update -
article pdf uploaded. 24 February 2023 06:48 CET Version of Record -
article supplementary file uploaded. 24 February 2023 06:48 CET - https://www.mdpi.com/2076-393X/11/3/535#supplementary
article html file updated 24 February 2023 06:49 CET Original file -
article xml file uploaded 24 February 2023 07:33 CET Update -
article xml uploaded. 24 February 2023 07:33 CET Update https://www.mdpi.com/2076-393X/11/3/535/xml
article pdf uploaded. 24 February 2023 07:33 CET Updated version of record https://www.mdpi.com/2076-393X/11/3/535/pdf
article html file updated 24 February 2023 07:34 CET Update -
article html file updated 9 March 2023 22:33 CET Update https://www.mdpi.com/2076-393X/11/3/535/html
Back to TopTop